Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.

Amparo Garcia-TejedorCatalina FaloSergi Fernandez-GonzalezMaria LaplanaMiguel Gil-GilTeresa Soler-MonsoEvelyn Martinez-PerezIris CalvoHugo CalpeloMaria-Teresa BajenAna BenitezRaul OrtegaAnna PetitAnna GumaMiriam CamposAgostina StradellaAna Lopez-OjedaJordi PonceMaria J PlaSonia Pernas

Published in: Breast cancer research and treatment (2023)

SLN positivity did not differ according to its timing (before or after NET). Therefore, NET has no effect on lymph node clearance. Furthermore, the prognosis is good regardless of the axillary involvement. Therefore, factors other than axillary involvement may affect the prognosis in these patients.

Keyphrases

lymph node
sentinel lymph node
neoadjuvant chemotherapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
early stage
rectal cancer
stem cells
ultrasound guided
body composition
squamous cell carcinoma
young adults
mesenchymal stem cells